Genetic and Environmental Epidemiology of Alzheimer's Disease in Arabs Residing in Israel

Journal of Molecular Neuroscience

Volumn 20, Issue 3, 2003, Pages 207-212

  Farrer, Lindsay A ^a,b   Friedland, Robert P ^c   Bowirrat, Abdalla ^a   Waraska, Kristin ^b   Korczyn, Amos ^d   Baldwin, Clinton T ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alzheimer's disese; Dementia; Israel genetic epidemiology

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARAB; ARTICLE; CHROMOSOME MAP; CHROMOSOME MARKER; CONSANGUINITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FAMILY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE ISOLATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC RISK; GENOME ANALYSIS; GENOMICS; HIGH RISK POPULATION; HUMAN; HUMAN GENOME; HYPOTHESIS; ISRAEL; LIPID DIET; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; SMOKING; CHROMOSOME 18; ENVIRONMENT; ETHNOLOGY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RISK FACTOR;

ARA;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ARABS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 18; CONSANGUINITY; DNA MUTATIONAL ANALYSIS; ENVIRONMENT; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; ISRAEL; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SMOKING;

EID: 0642279883     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:20:3:207     Document Type: Article

References (50)

1. Abraham R., Myers A., Wavrant-DeVrieze F., Hamshere M. L., Thomas H. V., Marshall H., Compton D., et al. (2001) Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum. Genet. 109, 646-652.
2. Baldwin C. T., Weiss S., Farrer L. A., et al. (1995) Linkage of congential, recessive deafness (DFNB4) to human chromosome 7q31 in the Middle Eastern Druze population and evidence for genetic heterogeneity. Hum. Mol. Genet. 4, 1637-1642.
3. Bertram L., Blacker D., Mullin K., et al. (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290, 2302-2303.
4. Blacker D., Wilcox M. A., Laird N. M., et al. (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19, 357-360.
5. Bonné-Tamir B., DeStefano A. L., Briggs C. E., et al. (1996) Linkage of congenital recessive deafness (DFNB10) to chromosome 21q22.3. Am. J. Hum. Genet. 58, 1254-1259.
6. Bowirrat A., Friedland R. P., Chapman J., and Korczyn A. D. (2000) The very high prevalence of Alzheimer's disease in an Arab population is not explained by APOE e4 allele frequency. Neurology 55, 731.
7. Bowirrat A., Treves T. A., Friedland R. P., and Korczyn A. D. (2001) Prevalence of Alzheimer's type dementia in an elderly Arab population. Eur. Neurol. 8, 1-5.
8. Brenner D. E., Kukull W. A., Van Belle G., et al. (1993) Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 43, 293-300.
9. Corder E. H., Saunders A. M., Strittmatter W. J., et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 261, 921-923.
10. Debanne S. M., Rowland D. Y., Riedel T. M., et al. (2000) Association of Alzheimer's disease and smoking: the case for sibling controls. J. Am. Geriatr. Soc. 48, 800-806.
11. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. (1994) American Psychiatric Association, Washington, D.C.
12. Doll R., Peto R., Boreham J., et al. (2000) Smoking and dementia in male British doctors: prospective study. Br. Med. J. 320, 1097-1102.
13. Doll R., Peto R., Wheatly K., et al. (1994) Mortality in relation to smoking: 40 years' observations on male British doctors. Br. Med. J. 309, 901-911.
14. Ertekin-Taner N., Graff-Radford N., Younkin L. H., et al. (2000) Linkage of plasma A42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290, 2303-2304.
15. Farrer L. A., Cupples L. A., Haines J. L., et al. (1997) Effects of age, gender and ethnicity on the association of apolipoprotein E genotype and Alzheimer disease. JAMA 278, 1349-1356.
16. Farrer L. A., Bowirrat A., Friedland, R. P., et al. (2003) Identification of multiple loci for Alzheimer's disease in a consanguineous Israeli-Arab community. Hum. Mol. Genet. 12, 415-422.
17. Ford A. B., Mefrouche Z., Friedland R., et al. (1996) Smoking and cognitive impairment: A population-based study. J. Am. Geriatr. Soc. 44, 905-909.
18. Frydman M., Bonné-Tamir B., Farrer L. A., Conneally P. M., Magazanik A., Ashbel S., and Goldwitch Z. (1985) Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase-D locus. Proc. Natl. Acad. Sci. U.S.A. 82, 1819-1821.
19. Graves A. B., Van Duijin C. M., Chandra V., et al. (1991) Alcohol and tobacco consumption as risk factors for Alzheimer ' s disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20, S48-S57.
20. Hendrie H. C., Ogunniyi A., Hall K. S., et al. (2001) Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 285, 739-747.
21. Jarvik G. P., Larson E. B., Goddard K., Kukull W. A., Schellenberg G. D., and Wijsman E. M. (1996) Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am. J. Hum. Genet. 58, 191-200.
22. Kang D. E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L. A., et al. (1997) Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49, 5661.
23. Koelega H. S. (1993) Stimulant drugs and vigilance performance: a review. Psychopharmacology 111, 1-16.
24. Korovaitseva G. I., Premkumar S., Grigorenko A., et al. (1999) Alpha-2 macroglobulin gene in early-and late-onset Alzheimer disease. Neurosci. Lett. 271, 129-131.
25. Lee P. N. (1994) Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology 13, 131-144.
26. Levin E. D., Conners C. K., Silvia D., et al. (1998) Transdermal nicotine effects on attention. Psychopharmacology 140, 135-141.
27. Mayeux R., Lee J. H., Romas S. N., et al. (2002) Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am. J. Hum. Genet. 70, 237-243.
28. Merchant C., Tang M.-X., Albert S., et al. (1999) The influence of smoking on the risk of Alzheimer's disease. Neurology 52, 1408-1412.
29. Myers A., Holmans P., Marshall H., et al. (2000) Susceptibility locus for Alzheimer's disease on chromosome 10. Science 290, 2304-2305.
30. Myers A. J. and Goate A. M. (2001) The genetics of late-onset Alzheimer's disease. Curr. Opin. Neurol. 14, 433-440.
31. Osuntokun B. O., Sahota A., Ogunniyi A. O., et al. (1995) Lack of an association between apolipoprotein E 4 and Alzheimer's disease in elderly Nigerians. Ann. Neurol. 38, 463-465.
32. Ott A., Slooter A. J. C., Hofman A., Van Harskamp J. C. M., et al. (1998) Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: The Rotterdam Study. Lancet 351, 1840-1843.
33. Pericak-Vance M. A., Bass M. P., Yamaoka L. H., et al. (1997) Complete genomic screen in late-onset familial Alzheimer disease: Evidence for a new locus on chromosome 12. JAMA 278, 1237-1241.
34. Pericak-Vance M. A., Grubber J., Bailey L. R., et al. (2000) Identification of novel genes in late-onset Alzheimer's disease. Exp. Gerontol. 35, 1343-1352.
35. Pericak-Vance M. A., Johnson C. C., Rimmler J. B., Saunders A. M., Robinson L. C., D'Hondt E. G., et al. (1996) Alzheimer's disease and apolipoprotein E-4 allele in an Amish population. Ann. Neurol. 39, 700-704.
36. Perry E. K., Gibson P. H., Blessed G., et al. (1977) Neurotransmitter enzyme abnormalities in senile dementia. J. Neurol. Sci. 34, 247-265.
37. Rao V. S., Cupples L. A., van Duijn C. M., et al. (1996) Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4. Am. J. Hum. Genet. 59, 664-675.
38. Rao V. S., van Duijn C. M., Connor-Lacke L., Growdon J. H., and Farrer L. A. (1994) Multiple etiologies for Alzheimer disease revealed by segregation analysis. Am. J. Hum. Genet. 55, 991-1000.
39. Riggs J. E. (1993) Smoking and Alzheimer's disease: protective effect or differential survival bias? Lancet 342, 792-794.
40. Rocca W. A., Hofman A., Brayne C., et al. (1991) Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. Ann. Neurol. 30, 381-390.
41. Rogaeva E., Premkumar S., Song Y., et al. (1998) Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 280, 614-618.
42. Rogaeva E. A., Premkumar S., Grubber J., et al. (1999) A comprehensive examination of an α-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat. Genet. 2, 19-20.
43. Schellenberg G. D., D'Souza I., and Poorkaj P. (2000) The genetics of Alzheimer's disease. Curr. Psychiatry Rep. 2, 158-164.
44. Scott W. K., Yamaoka L. H., Bass M. L., et al. (1998) No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease. Neurogenetics 1, 179-183.
45. Shimohama S., Taniguchi T., Fujiwara M., et al. (1986) Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer type dementia. J. Neurochem. 46, 288-293.
46. Terzano D. L., Beach T. G., Lukas R. J., et al. (1998) Immunohistochemical localization of nicotinic β2 and β4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observation. Neurosci. Lett. 256, 151-154.
47. Utsugisawa K., Nagane Y., Tongi H., et al. (1999) Changes with aging and ischemia in nicotinic acetylcholine receptor subunit α7 mRNA expression in postmortem human frontal cortex and putamen. Neurosci. 270, 145-148.
48. Van Duijn C. M., Farrer L. A., Cupples L. A., and Hofman A. (1993) Genetic transmission for Alzheimer disease among patients identified in a Dutch population based survey. J. Med. Genet. 30, 640-646.
49. Van Duijn C. N., Clayton D. G., Chandra V., et al. (1994) Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. Genet. Epidemiol. 11, 539-551.
50. 3H) nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology 39, 720-723.